Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AstraZeneca Stock Was a Winner Today

TheMotleyFool

0 0

Why AstraZeneca Stock Was a Winner Today: https://g.foolcdn.com/editorial/images/842033/person-in-a-lab-gazing-into-a-microscope.jpg

Good news from the laboratory put some zip into (NASDAQ: AZN) shares on Monday. The veteran pharmaceutical company's shares enjoyed a nearly 3% lift across the trading session as a consequence, a rate that convincingly outpaced the S 500 index's 1.5% growth.

Early this morning, AstraZeneca shared the results of a phase 3 clinical trial of baxdrostat, its investigational drug for treatment-resistant hypertension (i.e., high blood pressure).

Image source: Getty Images.

Source Fool.com